Facility Details

The Emory University Lipidomics Core Facility will provide quantitative lipidomics analyses on lipid samples from a wide variety of biological matrices, e.g. blood, serum, plasma, solid tissues, cell extracts, etc., to support both clinical and basic research efforts on campus. These analyses will provide insight on lipids and lipid precursors whose abundance can be monitored as biomarkers to predict and follow progression of a wide range of diseases, such as metabolic disorders (e.g.. obesity, Type II diabetes, and NAFLD), neurodegenerative diseases (e.g. Alzheimer’s Disease and Parkinson’s Disease), and cancer (e.g. prostate cancer and breast cancer).